ORIGINAL RESEARCH
Published on 26 Feb 2025
Combination autologous stem cell transplantation with chimeric antigen receptor T-cell therapy for refractory/relapsed B-cell lymphoma: a single-arm clinical study
doi 10.3389/fimmu.2025.1532460
- 256 views
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Mechanisms and Therapeutic Opportunities of T Cell Impairment in Cancer Immunity and Immunotherapy
Mechanisms and Therapeutic Opportunities of T Cell Impairment in Cancer Immunity and Immunotherapy
3,586
Total downloads
12k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
BRIEF RESEARCH REPORT
Published on 25 Feb 2025
Co-expression of B7-H3 and LAG3 represents cytotoxicity of CD4+ T cells in humans
doi 10.3389/fimmu.2025.1560383
- 537 views
ORIGINAL RESEARCH
Published on 30 Jan 2025
Disulfidptosis as a key regulator of glioblastoma progression and immune cell impairment
doi 10.3389/fimmu.2025.1526296
- 502 views
ORIGINAL RESEARCH
Published on 24 Jan 2025
Aging impairs CD8 T cell responses in adoptive T-cell therapy against solid tumors
doi 10.3389/fimmu.2025.1484303
- 916 views
ORIGINAL RESEARCH
Published on 14 Jan 2025
Bryostatin-1 enhances the proliferation and functionality of exhausted CD8+ T cells by upregulating MAP Kinase 11
doi 10.3389/fimmu.2024.1509874
- 630 views
MINI REVIEW
Published on 09 Dec 2024
CD8+ T cell exhaustion in the tumor microenvironment of breast cancer
doi 10.3389/fimmu.2024.1507283
- 1,064 views
- 3 citations
ORIGINAL RESEARCH
Published on 07 Nov 2024
Integrated analysis of single-cell, spatial and bulk RNA-sequencing identifies a cell-death signature for predicting the outcomes of head and neck cancer
doi 10.3389/fimmu.2024.1487966
- 2,144 views
CLINICAL TRIAL
Published on 20 Aug 2024
Clinical trial: Chidamide plus CHOP improve the survival of newly diagnosed angioimmunoblastic T-cell lymphoma
doi 10.3389/fimmu.2024.1430648
- 1,070 views
ORIGINAL RESEARCH
Published on 17 Jul 2024
Integrative single-cell analysis of longitudinal t(8;21) AML reveals heterogeneous immune cell infiltration and prognostic signatures
doi 10.3389/fimmu.2024.1424933
- 1,469 views
- 1 citation
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
T Cell Biology
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: